School of Sport, Exercise and Health Sciences, Loughborough University, Epinal Way, Loughborough, LE11 3TU, UK.
Matern Child Health J. 2024 Mar;28(3):557-566. doi: 10.1007/s10995-023-03851-w. Epub 2023 Nov 29.
To examine the relationships between gestational diabetes mellitus (GDM) treatment and neonatal anthropometry.
Covariate-adjusted multivariable linear regression analyses were used in 9907 offspring of the Born in Bradford cohort. GDM treatment type (lifestyle changes advice only, lifestyle changes and insulin or lifestyle changes and metformin) was the exposure, offspring born to mothers without GDM the control, and birth weight, head, mid-arm and abdominal circumference, and subscapular and triceps skinfold thickness the outcomes.
Lower birth weight in offspring exposed to insulin (- 117.2 g (95% CI - 173.8, - 60.7)) and metformin (- 200.3 g (- 328.5, - 72.1)) compared to offspring not exposed to GDM was partly attributed to lower gestational age at birth and greater proportion of Pakistani mothers in the treatment groups. Higher subscapular skinfolds in offspring exposed to treatment compared to those not exposed to GDM was partly attributed to higher maternal glucose concentrations at diagnosis. In fully adjusted analyses, offspring exposed to GDM treatment had lower weight, smaller abdominal circumference and skinfolds at birth than those not exposed to GDM. Metformin exposure was associated with smaller offspring mid-arm circumference (- 0.3 cm (- 0.6, - 0.07)) than insulin exposure in fully adjusted models with no other differences found.
Offspring exposed to GDM treatment were lighter and smaller at birth than those not exposed to GDM. Metformin-exposed offspring had largely comparable birth anthropometric characteristics to those exposed to insulin.
研究妊娠期糖尿病(GDM)治疗与新生儿人体测量学的关系。
在布拉德福德出生队列的 9907 名后代中,采用协变量调整的多变量线性回归分析。GDM 治疗类型(仅生活方式改变建议、生活方式改变加胰岛素或生活方式改变加二甲双胍)为暴露因素,未患 GDM 的母亲所生的后代为对照,出生体重、头围、中臂围和腹围以及肩胛下和肱三头肌皮褶厚度为结局。
与未暴露于 GDM 的后代相比,暴露于胰岛素(-117.2g(95%CI-173.8,-60.7))和二甲双胍(-200.3g(-328.5,-72.1))的后代出生体重较低,这部分归因于出生时胎龄较低以及治疗组中巴基斯坦裔母亲的比例较高。与未暴露于 GDM 的后代相比,接受治疗的后代肩胛下皮褶厚度较高,这部分归因于诊断时母体葡萄糖浓度较高。在完全调整的分析中,与未暴露于 GDM 的后代相比,暴露于 GDM 治疗的后代出生时体重、腹围和皮褶较小。在完全调整模型中,与胰岛素暴露相比,二甲双胍暴露与后代中臂围较小(-0.3cm(-0.6,-0.07))相关,未发现其他差异。
暴露于 GDM 治疗的后代出生时体重较轻,体型较小。与胰岛素暴露相比,二甲双胍暴露的后代出生时的人体测量特征基本相似。